Target intelligence / Profile preview

Endogenous extracellular matrix molecules (ECM)

Target
ECM
Molecular classification
Structural protein, Proteoglycan, Glycosaminoglycan, Glycoprotein
01

Overview

The endogenous extracellular matrix (ECM) is a complex, non-cellular three-dimensional macromolecular network composed of collagens, proteoglycans, glycosaminoglycans, and glycoproteins that provide essential structural and biochemical support to tissues (Frantz et al., 2010, J Cell Sci). Beyond its role as a physical scaffold, the ECM acts as a dynamic signaling hub, regulating cell behavior such as proliferation, migration, and differentiation through interactions with cell-surface receptors like integrins (Hynes, 2009, Science). In various diseases, the ECM undergoes pathological remodeling; for instance, excessive deposition of collagen leads to organ fibrosis, while the degradation of matrix components by enzymes like matrix metalloproteinases (MMPs) facilitates tumor invasion and metastasis (Lu et al., 2012, J Cell Biol). Pharmacological targeting of the ECM is a diverse field, ranging from the use of enzymatic agents like collagenase clostridium histolyticum to treat Dupuytren's contracture to the application of hyaluronidase to increase tissue permeability for drug delivery (Hurst et al., 2009, N Engl J Med; Bookbinder et al., 2006, J Control Release). Additionally, exogenous ECM molecules like hyaluronic acid and chondroitin sulfate are utilized as viscosupplements in the management of osteoarthritis (Bannuru et al., 2019, Ann Intern Med). While the ECM presents a rich landscape for therapeutic intervention, its ubiquitous presence in the body necessitates high specificity to avoid adverse effects on normal tissue architecture and the body's natural repair mechanisms.

Other names
Extracellular matrixECM componentsMatrisomeIntercellular matrixConnective tissue matrix
02

Mechanism of action

Therapeutic strategies involve the enzymatic degradation of accumulated matrix components (e.g., collagen or hyaluronan), the inhibition of cross-linking enzymes such as lysyl oxidase-like 2 (LOXL2) to prevent matrix stiffening, or the use of exogenous ECM components to restore tissue lubrication and integrity.

03

Biological functions

Structural supportCell adhesionCell signalingTissue remodelingGrowth factor sequestrationWound healing
04

Disease associations

CancerFibrosisOsteoarthritisCardiovascular diseaseGenetic disorders (e.g., Ehlers-Danlos syndrome)
05

Safety considerations

Impaired wound healingRisk of tissue or tendon ruptureHypersensitivity and injection site reactionsPotential for systemic degradation of healthy connective tissue
06

Interacting drugs

Collagenase clostridium histolyticum

5 more in the full profile.

07

Biomarkers

Pro-collagen type III N-terminal peptide (PIIINP)C-terminal telopeptide of type I collagen (CTX-I)Hyaluronic acid levelsFibronectinMatrix metalloproteinase (MMP) levels

Beyond the preview

Go deeper on Endogenous extracellular matrix molecules (ECM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endogenous extracellular matrix molecules (ECM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call